Immunic, Inc. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported net loss was USD 25.27 million compared to USD 20.81 million a year ago. Basic loss per share from continuing operations was USD 0.58 compared to USD 0.74 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.24 USD | +1.64% | -0.80% | -17.33% |
08/05 | Transcript : Immunic, Inc., Q1 2024 Earnings Call, May 08, 2024 | |
08/05 | Immunic, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.33% | 11Cr | |
+11.91% | 12TCr | |
+11.60% | 11TCr | |
-4.68% | 2.43TCr | |
-0.82% | 2.2TCr | |
-10.12% | 1.82TCr | |
-42.12% | 1.64TCr | |
-17.47% | 1.56TCr | |
+2.77% | 1.36TCr | |
+34.58% | 1.23TCr |
- Stock Market
- Equities
- IMUX Stock
- News Immunic, Inc.
- Immunic, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023